tiprankstipranks
CanSino Biologics, Inc. Class H (HK:6185)
:6185
6185
CanSino Biologics, Inc. Class H
RESEARCH TOOLSreports

CanSino Biologics, Inc. Class H (6185) Revenue

Compare
5 Followers
StatisticsMarket CapRevenue

CanSino Biologics, Inc. Class H Revenue

CanSino Biologics, Inc. Class H had a revenue of 310.14M in the quarter ending Sep 30, 2025, with 26.50%. This bring the company's revenue in the last twelve months to 971.73M, Decreased 5.02%. In the fiscal year ending Dec 31, 2024, CanSino Biologics, Inc. Class H had annual revenue of 846.34M with 145.19% growth.
Revenue (ttm)
971.73M
Revenue Growth
29.21%
P/S Ratio
15.48
Revenue/Employee
HK$765,917
Employees
1,105
Market Cap
HK$13.10B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
846.34M501.16M+145.19%
Dec 31, 2023
345.18M-685.86M-66.52%
Dec 31, 2022
1.03B-3.27B-76.02%
Dec 31, 2021
4.30B4.27B+17,174.82%
Dec 31, 2020
24.89M22.61M+990.05%
Dec 31, 2019
2.28M1.15M+101.71%
Dec 31, 2018
1.13M-8.05M-87.67%
Dec 31, 2017
9.18M――